Global Parkinson's Disease (PD) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Parkinson's Disease (PD) Drugs market size was valued at USD 5651 million in 2023 and is forecast to a readjusted size of USD 7494.1 million by 2030 with a CAGR of 4.1% during review period.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
The Global Info Research report includes an overview of the development of the Parkinson's Disease (PD) Drugs industry chain, the market status of Hospital (Dopamine Agonist, Monoamine Oxidase Inhibitors), Family (Dopamine Agonist, Monoamine Oxidase Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parkinson's Disease (PD) Drugs.
Regionally, the report analyzes the Parkinson's Disease (PD) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parkinson's Disease (PD) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parkinson's Disease (PD) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parkinson's Disease (PD) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Dopamine Agonist, Monoamine Oxidase Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parkinson's Disease (PD) Drugs market.
Regional Analysis: The report involves examining the Parkinson's Disease (PD) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parkinson's Disease (PD) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parkinson's Disease (PD) Drugs:
Company Analysis: Report covers individual Parkinson's Disease (PD) Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parkinson's Disease (PD) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Family).
Technology Analysis: Report covers specific technologies relevant to Parkinson's Disease (PD) Drugs. It assesses the current state, advancements, and potential future developments in Parkinson's Disease (PD) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parkinson's Disease (PD) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parkinson's Disease (PD) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Parkinson's Disease (PD) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Parkinson's Disease (PD) Drugs, with price, sales, revenue and global market share of Parkinson's Disease (PD) Drugs from 2019 to 2024.
Chapter 3, the Parkinson's Disease (PD) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parkinson's Disease (PD) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Parkinson's Disease (PD) Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Parkinson's Disease (PD) Drugs.
Chapter 14 and 15, to describe Parkinson's Disease (PD) Drugs sales channel, distributors, customers, research findings and conclusion.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
The Global Info Research report includes an overview of the development of the Parkinson's Disease (PD) Drugs industry chain, the market status of Hospital (Dopamine Agonist, Monoamine Oxidase Inhibitors), Family (Dopamine Agonist, Monoamine Oxidase Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parkinson's Disease (PD) Drugs.
Regionally, the report analyzes the Parkinson's Disease (PD) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parkinson's Disease (PD) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parkinson's Disease (PD) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parkinson's Disease (PD) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Dopamine Agonist, Monoamine Oxidase Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parkinson's Disease (PD) Drugs market.
Regional Analysis: The report involves examining the Parkinson's Disease (PD) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parkinson's Disease (PD) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parkinson's Disease (PD) Drugs:
Company Analysis: Report covers individual Parkinson's Disease (PD) Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parkinson's Disease (PD) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Family).
Technology Analysis: Report covers specific technologies relevant to Parkinson's Disease (PD) Drugs. It assesses the current state, advancements, and potential future developments in Parkinson's Disease (PD) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parkinson's Disease (PD) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parkinson's Disease (PD) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Dopamine Agonist
- Monoamine Oxidase Inhibitors
- Acetylcholinesterase Inhibitors
- Glutamate Inhibitors
- Hospital
- Family
- Boehringer Ingelheim
- GlaxoSmithKline
- Novartis
- Teva Pharmaceutical Industries
- AbbVie
- Abital Pharma
- Addex Therapeutics
- Biogen
- Eisai
- Eli Lilly
- F. Hoffmann-La Roche
- H. Lundbeck
- Impax Laboratories
- Kyowa Hakko Kirin
- Otsuka Pharmaceutical
- Pfizer
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Parkinson's Disease (PD) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Parkinson's Disease (PD) Drugs, with price, sales, revenue and global market share of Parkinson's Disease (PD) Drugs from 2019 to 2024.
Chapter 3, the Parkinson's Disease (PD) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parkinson's Disease (PD) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Parkinson's Disease (PD) Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Parkinson's Disease (PD) Drugs.
Chapter 14 and 15, to describe Parkinson's Disease (PD) Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Parkinson's Disease (PD) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Parkinson's Disease (PD) Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Dopamine Agonist
1.3.3 Monoamine Oxidase Inhibitors
1.3.4 Acetylcholinesterase Inhibitors
1.3.5 Glutamate Inhibitors
1.4 Market Analysis by Application
1.4.1 Overview: Global Parkinson's Disease (PD) Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Family
1.5 Global Parkinson's Disease (PD) Drugs Market Size & Forecast
1.5.1 Global Parkinson's Disease (PD) Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Parkinson's Disease (PD) Drugs Sales Quantity (2019-2030)
1.5.3 Global Parkinson's Disease (PD) Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product and Services
2.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product and Services
2.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Parkinson's Disease (PD) Drugs Product and Services
2.3.4 Novartis Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Teva Pharmaceutical Industries
2.4.1 Teva Pharmaceutical Industries Details
2.4.2 Teva Pharmaceutical Industries Major Business
2.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product and Services
2.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Parkinson's Disease (PD) Drugs Product and Services
2.5.4 AbbVie Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AbbVie Recent Developments/Updates
2.6 Abital Pharma
2.6.1 Abital Pharma Details
2.6.2 Abital Pharma Major Business
2.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Product and Services
2.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abital Pharma Recent Developments/Updates
2.7 Addex Therapeutics
2.7.1 Addex Therapeutics Details
2.7.2 Addex Therapeutics Major Business
2.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product and Services
2.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Addex Therapeutics Recent Developments/Updates
2.8 Biogen
2.8.1 Biogen Details
2.8.2 Biogen Major Business
2.8.3 Biogen Parkinson's Disease (PD) Drugs Product and Services
2.8.4 Biogen Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biogen Recent Developments/Updates
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Parkinson's Disease (PD) Drugs Product and Services
2.9.4 Eisai Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eisai Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Product and Services
2.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 F. Hoffmann-La Roche
2.11.1 F. Hoffmann-La Roche Details
2.11.2 F. Hoffmann-La Roche Major Business
2.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product and Services
2.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 F. Hoffmann-La Roche Recent Developments/Updates
2.12 H. Lundbeck
2.12.1 H. Lundbeck Details
2.12.2 H. Lundbeck Major Business
2.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Product and Services
2.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 H. Lundbeck Recent Developments/Updates
2.13 Impax Laboratories
2.13.1 Impax Laboratories Details
2.13.2 Impax Laboratories Major Business
2.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product and Services
2.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Impax Laboratories Recent Developments/Updates
2.14 Kyowa Hakko Kirin
2.14.1 Kyowa Hakko Kirin Details
2.14.2 Kyowa Hakko Kirin Major Business
2.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product and Services
2.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Kyowa Hakko Kirin Recent Developments/Updates
2.15 Otsuka Pharmaceutical
2.15.1 Otsuka Pharmaceutical Details
2.15.2 Otsuka Pharmaceutical Major Business
2.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product and Services
2.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Otsuka Pharmaceutical Recent Developments/Updates
2.16 Pfizer
2.16.1 Pfizer Details
2.16.2 Pfizer Major Business
2.16.3 Pfizer Parkinson's Disease (PD) Drugs Product and Services
2.16.4 Pfizer Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Pfizer Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PARKINSON'S DISEASE (PD) DRUGS BY MANUFACTURER
3.1 Global Parkinson's Disease (PD) Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Parkinson's Disease (PD) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Parkinson's Disease (PD) Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Parkinson's Disease (PD) Drugs Manufacturer Market Share in 2023
3.5 Parkinson's Disease (PD) Drugs Market: Overall Company Footprint Analysis
3.5.1 Parkinson's Disease (PD) Drugs Market: Region Footprint
3.5.2 Parkinson's Disease (PD) Drugs Market: Company Product Type Footprint
3.5.3 Parkinson's Disease (PD) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Parkinson's Disease (PD) Drugs Market Size by Region
4.1.1 Global Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Parkinson's Disease (PD) Drugs Average Price by Region (2019-2030)
4.2 North America Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
4.3 Europe Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
4.5 South America Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
5.2 Global Parkinson's Disease (PD) Drugs Consumption Value by Type (2019-2030)
5.3 Global Parkinson's Disease (PD) Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
6.2 Global Parkinson's Disease (PD) Drugs Consumption Value by Application (2019-2030)
6.3 Global Parkinson's Disease (PD) Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
7.2 North America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
7.3 North America Parkinson's Disease (PD) Drugs Market Size by Country
7.3.1 North America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Parkinson's Disease (PD) Drugs Market Size by Country
8.3.1 Europe Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size by Region
9.3.1 Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
10.2 South America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
10.3 South America Parkinson's Disease (PD) Drugs Market Size by Country
10.3.1 South America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Parkinson's Disease (PD) Drugs Market Size by Country
11.3.1 Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Parkinson's Disease (PD) Drugs Market Drivers
12.2 Parkinson's Disease (PD) Drugs Market Restraints
12.3 Parkinson's Disease (PD) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Parkinson's Disease (PD) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Parkinson's Disease (PD) Drugs
13.3 Parkinson's Disease (PD) Drugs Production Process
13.4 Parkinson's Disease (PD) Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Parkinson's Disease (PD) Drugs Typical Distributors
14.3 Parkinson's Disease (PD) Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Parkinson's Disease (PD) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Parkinson's Disease (PD) Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Dopamine Agonist
1.3.3 Monoamine Oxidase Inhibitors
1.3.4 Acetylcholinesterase Inhibitors
1.3.5 Glutamate Inhibitors
1.4 Market Analysis by Application
1.4.1 Overview: Global Parkinson's Disease (PD) Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Family
1.5 Global Parkinson's Disease (PD) Drugs Market Size & Forecast
1.5.1 Global Parkinson's Disease (PD) Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Parkinson's Disease (PD) Drugs Sales Quantity (2019-2030)
1.5.3 Global Parkinson's Disease (PD) Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product and Services
2.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product and Services
2.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Parkinson's Disease (PD) Drugs Product and Services
2.3.4 Novartis Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Teva Pharmaceutical Industries
2.4.1 Teva Pharmaceutical Industries Details
2.4.2 Teva Pharmaceutical Industries Major Business
2.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product and Services
2.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Parkinson's Disease (PD) Drugs Product and Services
2.5.4 AbbVie Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AbbVie Recent Developments/Updates
2.6 Abital Pharma
2.6.1 Abital Pharma Details
2.6.2 Abital Pharma Major Business
2.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Product and Services
2.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abital Pharma Recent Developments/Updates
2.7 Addex Therapeutics
2.7.1 Addex Therapeutics Details
2.7.2 Addex Therapeutics Major Business
2.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product and Services
2.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Addex Therapeutics Recent Developments/Updates
2.8 Biogen
2.8.1 Biogen Details
2.8.2 Biogen Major Business
2.8.3 Biogen Parkinson's Disease (PD) Drugs Product and Services
2.8.4 Biogen Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biogen Recent Developments/Updates
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Parkinson's Disease (PD) Drugs Product and Services
2.9.4 Eisai Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eisai Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Product and Services
2.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 F. Hoffmann-La Roche
2.11.1 F. Hoffmann-La Roche Details
2.11.2 F. Hoffmann-La Roche Major Business
2.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product and Services
2.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 F. Hoffmann-La Roche Recent Developments/Updates
2.12 H. Lundbeck
2.12.1 H. Lundbeck Details
2.12.2 H. Lundbeck Major Business
2.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Product and Services
2.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 H. Lundbeck Recent Developments/Updates
2.13 Impax Laboratories
2.13.1 Impax Laboratories Details
2.13.2 Impax Laboratories Major Business
2.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product and Services
2.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Impax Laboratories Recent Developments/Updates
2.14 Kyowa Hakko Kirin
2.14.1 Kyowa Hakko Kirin Details
2.14.2 Kyowa Hakko Kirin Major Business
2.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product and Services
2.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Kyowa Hakko Kirin Recent Developments/Updates
2.15 Otsuka Pharmaceutical
2.15.1 Otsuka Pharmaceutical Details
2.15.2 Otsuka Pharmaceutical Major Business
2.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product and Services
2.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Otsuka Pharmaceutical Recent Developments/Updates
2.16 Pfizer
2.16.1 Pfizer Details
2.16.2 Pfizer Major Business
2.16.3 Pfizer Parkinson's Disease (PD) Drugs Product and Services
2.16.4 Pfizer Parkinson's Disease (PD) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Pfizer Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PARKINSON'S DISEASE (PD) DRUGS BY MANUFACTURER
3.1 Global Parkinson's Disease (PD) Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Parkinson's Disease (PD) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Parkinson's Disease (PD) Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Parkinson's Disease (PD) Drugs Manufacturer Market Share in 2023
3.5 Parkinson's Disease (PD) Drugs Market: Overall Company Footprint Analysis
3.5.1 Parkinson's Disease (PD) Drugs Market: Region Footprint
3.5.2 Parkinson's Disease (PD) Drugs Market: Company Product Type Footprint
3.5.3 Parkinson's Disease (PD) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Parkinson's Disease (PD) Drugs Market Size by Region
4.1.1 Global Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Parkinson's Disease (PD) Drugs Average Price by Region (2019-2030)
4.2 North America Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
4.3 Europe Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
4.5 South America Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Parkinson's Disease (PD) Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
5.2 Global Parkinson's Disease (PD) Drugs Consumption Value by Type (2019-2030)
5.3 Global Parkinson's Disease (PD) Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
6.2 Global Parkinson's Disease (PD) Drugs Consumption Value by Application (2019-2030)
6.3 Global Parkinson's Disease (PD) Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
7.2 North America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
7.3 North America Parkinson's Disease (PD) Drugs Market Size by Country
7.3.1 North America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Parkinson's Disease (PD) Drugs Market Size by Country
8.3.1 Europe Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size by Region
9.3.1 Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
10.2 South America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
10.3 South America Parkinson's Disease (PD) Drugs Market Size by Country
10.3.1 South America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Parkinson's Disease (PD) Drugs Market Size by Country
11.3.1 Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Parkinson's Disease (PD) Drugs Market Drivers
12.2 Parkinson's Disease (PD) Drugs Market Restraints
12.3 Parkinson's Disease (PD) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Parkinson's Disease (PD) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Parkinson's Disease (PD) Drugs
13.3 Parkinson's Disease (PD) Drugs Production Process
13.4 Parkinson's Disease (PD) Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Parkinson's Disease (PD) Drugs Typical Distributors
14.3 Parkinson's Disease (PD) Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Parkinson's Disease (PD) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parkinson's Disease (PD) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product and Services
Table 6. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Boehringer Ingelheim Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product and Services
Table 11. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Parkinson's Disease (PD) Drugs Product and Services
Table 16. Novartis Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis Recent Developments/Updates
Table 18. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 19. Teva Pharmaceutical Industries Major Business
Table 20. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product and Services
Table 21. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Teva Pharmaceutical Industries Recent Developments/Updates
Table 23. AbbVie Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Major Business
Table 25. AbbVie Parkinson's Disease (PD) Drugs Product and Services
Table 26. AbbVie Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. AbbVie Recent Developments/Updates
Table 28. Abital Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Abital Pharma Major Business
Table 30. Abital Pharma Parkinson's Disease (PD) Drugs Product and Services
Table 31. Abital Pharma Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Abital Pharma Recent Developments/Updates
Table 33. Addex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Addex Therapeutics Major Business
Table 35. Addex Therapeutics Parkinson's Disease (PD) Drugs Product and Services
Table 36. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Addex Therapeutics Recent Developments/Updates
Table 38. Biogen Basic Information, Manufacturing Base and Competitors
Table 39. Biogen Major Business
Table 40. Biogen Parkinson's Disease (PD) Drugs Product and Services
Table 41. Biogen Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Biogen Recent Developments/Updates
Table 43. Eisai Basic Information, Manufacturing Base and Competitors
Table 44. Eisai Major Business
Table 45. Eisai Parkinson's Disease (PD) Drugs Product and Services
Table 46. Eisai Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eisai Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Parkinson's Disease (PD) Drugs Product and Services
Table 51. Eli Lilly Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 54. F. Hoffmann-La Roche Major Business
Table 55. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product and Services
Table 56. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. F. Hoffmann-La Roche Recent Developments/Updates
Table 58. H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 59. H. Lundbeck Major Business
Table 60. H. Lundbeck Parkinson's Disease (PD) Drugs Product and Services
Table 61. H. Lundbeck Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. H. Lundbeck Recent Developments/Updates
Table 63. Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Impax Laboratories Major Business
Table 65. Impax Laboratories Parkinson's Disease (PD) Drugs Product and Services
Table 66. Impax Laboratories Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Impax Laboratories Recent Developments/Updates
Table 68. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 69. Kyowa Hakko Kirin Major Business
Table 70. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product and Services
Table 71. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Kyowa Hakko Kirin Recent Developments/Updates
Table 73. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Otsuka Pharmaceutical Major Business
Table 75. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product and Services
Table 76. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Otsuka Pharmaceutical Recent Developments/Updates
Table 78. Pfizer Basic Information, Manufacturing Base and Competitors
Table 79. Pfizer Major Business
Table 80. Pfizer Parkinson's Disease (PD) Drugs Product and Services
Table 81. Pfizer Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Pfizer Recent Developments/Updates
Table 83. Global Parkinson's Disease (PD) Drugs Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 84. Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global Parkinson's Disease (PD) Drugs Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 86. Market Position of Manufacturers in Parkinson's Disease (PD) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 87. Head Office and Parkinson's Disease (PD) Drugs Production Site of Key Manufacturer
Table 88. Parkinson's Disease (PD) Drugs Market: Company Product Type Footprint
Table 89. Parkinson's Disease (PD) Drugs Market: Company Product Application Footprint
Table 90. Parkinson's Disease (PD) Drugs New Market Entrants and Barriers to Market Entry
Table 91. Parkinson's Disease (PD) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 93. Global Parkinson's Disease (PD) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 94. Global Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Global Parkinson's Disease (PD) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 96. Global Parkinson's Disease (PD) Drugs Average Price by Region (2019-2024) & (USD/Pcs)
Table 97. Global Parkinson's Disease (PD) Drugs Average Price by Region (2025-2030) & (USD/Pcs)
Table 98. Global Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 99. Global Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 100. Global Parkinson's Disease (PD) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Global Parkinson's Disease (PD) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Global Parkinson's Disease (PD) Drugs Average Price by Type (2019-2024) & (USD/Pcs)
Table 103. Global Parkinson's Disease (PD) Drugs Average Price by Type (2025-2030) & (USD/Pcs)
Table 104. Global Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 105. Global Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 106. Global Parkinson's Disease (PD) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 107. Global Parkinson's Disease (PD) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 108. Global Parkinson's Disease (PD) Drugs Average Price by Application (2019-2024) & (USD/Pcs)
Table 109. Global Parkinson's Disease (PD) Drugs Average Price by Application (2025-2030) & (USD/Pcs)
Table 110. North America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 111. North America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 112. North America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 113. North America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 114. North America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 115. North America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 116. North America Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 117. North America Parkinson's Disease (PD) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 119. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 120. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 121. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 122. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 123. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 124. Europe Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Parkinson's Disease (PD) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 127. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 128. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 129. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 130. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 131. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 132. Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 133. Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 134. South America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 135. South America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 136. South America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 137. South America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 138. South America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 139. South America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 140. South America Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 141. South America Parkinson's Disease (PD) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 143. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 144. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 145. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 146. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 147. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 148. Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 150. Parkinson's Disease (PD) Drugs Raw Material
Table 151. Key Manufacturers of Parkinson's Disease (PD) Drugs Raw Materials
Table 152. Parkinson's Disease (PD) Drugs Typical Distributors
Table 153. Parkinson's Disease (PD) Drugs Typical Customers
Table 1. Global Parkinson's Disease (PD) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parkinson's Disease (PD) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product and Services
Table 6. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Boehringer Ingelheim Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product and Services
Table 11. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Parkinson's Disease (PD) Drugs Product and Services
Table 16. Novartis Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis Recent Developments/Updates
Table 18. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 19. Teva Pharmaceutical Industries Major Business
Table 20. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product and Services
Table 21. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Teva Pharmaceutical Industries Recent Developments/Updates
Table 23. AbbVie Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Major Business
Table 25. AbbVie Parkinson's Disease (PD) Drugs Product and Services
Table 26. AbbVie Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. AbbVie Recent Developments/Updates
Table 28. Abital Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Abital Pharma Major Business
Table 30. Abital Pharma Parkinson's Disease (PD) Drugs Product and Services
Table 31. Abital Pharma Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Abital Pharma Recent Developments/Updates
Table 33. Addex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Addex Therapeutics Major Business
Table 35. Addex Therapeutics Parkinson's Disease (PD) Drugs Product and Services
Table 36. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Addex Therapeutics Recent Developments/Updates
Table 38. Biogen Basic Information, Manufacturing Base and Competitors
Table 39. Biogen Major Business
Table 40. Biogen Parkinson's Disease (PD) Drugs Product and Services
Table 41. Biogen Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Biogen Recent Developments/Updates
Table 43. Eisai Basic Information, Manufacturing Base and Competitors
Table 44. Eisai Major Business
Table 45. Eisai Parkinson's Disease (PD) Drugs Product and Services
Table 46. Eisai Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eisai Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Parkinson's Disease (PD) Drugs Product and Services
Table 51. Eli Lilly Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 54. F. Hoffmann-La Roche Major Business
Table 55. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product and Services
Table 56. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. F. Hoffmann-La Roche Recent Developments/Updates
Table 58. H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 59. H. Lundbeck Major Business
Table 60. H. Lundbeck Parkinson's Disease (PD) Drugs Product and Services
Table 61. H. Lundbeck Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. H. Lundbeck Recent Developments/Updates
Table 63. Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Impax Laboratories Major Business
Table 65. Impax Laboratories Parkinson's Disease (PD) Drugs Product and Services
Table 66. Impax Laboratories Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Impax Laboratories Recent Developments/Updates
Table 68. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 69. Kyowa Hakko Kirin Major Business
Table 70. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product and Services
Table 71. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Kyowa Hakko Kirin Recent Developments/Updates
Table 73. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Otsuka Pharmaceutical Major Business
Table 75. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product and Services
Table 76. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Otsuka Pharmaceutical Recent Developments/Updates
Table 78. Pfizer Basic Information, Manufacturing Base and Competitors
Table 79. Pfizer Major Business
Table 80. Pfizer Parkinson's Disease (PD) Drugs Product and Services
Table 81. Pfizer Parkinson's Disease (PD) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Pfizer Recent Developments/Updates
Table 83. Global Parkinson's Disease (PD) Drugs Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 84. Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global Parkinson's Disease (PD) Drugs Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 86. Market Position of Manufacturers in Parkinson's Disease (PD) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 87. Head Office and Parkinson's Disease (PD) Drugs Production Site of Key Manufacturer
Table 88. Parkinson's Disease (PD) Drugs Market: Company Product Type Footprint
Table 89. Parkinson's Disease (PD) Drugs Market: Company Product Application Footprint
Table 90. Parkinson's Disease (PD) Drugs New Market Entrants and Barriers to Market Entry
Table 91. Parkinson's Disease (PD) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 93. Global Parkinson's Disease (PD) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 94. Global Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Global Parkinson's Disease (PD) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 96. Global Parkinson's Disease (PD) Drugs Average Price by Region (2019-2024) & (USD/Pcs)
Table 97. Global Parkinson's Disease (PD) Drugs Average Price by Region (2025-2030) & (USD/Pcs)
Table 98. Global Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 99. Global Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 100. Global Parkinson's Disease (PD) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Global Parkinson's Disease (PD) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Global Parkinson's Disease (PD) Drugs Average Price by Type (2019-2024) & (USD/Pcs)
Table 103. Global Parkinson's Disease (PD) Drugs Average Price by Type (2025-2030) & (USD/Pcs)
Table 104. Global Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 105. Global Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 106. Global Parkinson's Disease (PD) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 107. Global Parkinson's Disease (PD) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 108. Global Parkinson's Disease (PD) Drugs Average Price by Application (2019-2024) & (USD/Pcs)
Table 109. Global Parkinson's Disease (PD) Drugs Average Price by Application (2025-2030) & (USD/Pcs)
Table 110. North America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 111. North America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 112. North America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 113. North America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 114. North America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 115. North America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 116. North America Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 117. North America Parkinson's Disease (PD) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 119. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 120. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 121. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 122. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 123. Europe Parkinson's Disease (PD) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 124. Europe Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Parkinson's Disease (PD) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 127. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 128. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 129. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 130. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 131. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 132. Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 133. Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 134. South America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 135. South America Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 136. South America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 137. South America Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 138. South America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 139. South America Parkinson's Disease (PD) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 140. South America Parkinson's Disease (PD) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 141. South America Parkinson's Disease (PD) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 143. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 144. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 145. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 146. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 147. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 148. Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 150. Parkinson's Disease (PD) Drugs Raw Material
Table 151. Key Manufacturers of Parkinson's Disease (PD) Drugs Raw Materials
Table 152. Parkinson's Disease (PD) Drugs Typical Distributors
Table 153. Parkinson's Disease (PD) Drugs Typical Customers
LIST OF FIGURES
Figure 1. Parkinson's Disease (PD) Drugs Picture
Figure 2. Global Parkinson's Disease (PD) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Type in 2023
Figure 4. Dopamine Agonist Examples
Figure 5. Monoamine Oxidase Inhibitors Examples
Figure 6. Acetylcholinesterase Inhibitors Examples
Figure 7. Glutamate Inhibitors Examples
Figure 8. Global Parkinson's Disease (PD) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. Family Examples
Figure 12. Global Parkinson's Disease (PD) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Parkinson's Disease (PD) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Parkinson's Disease (PD) Drugs Sales Quantity (2019-2030) & (K Pcs)
Figure 15. Global Parkinson's Disease (PD) Drugs Average Price (2019-2030) & (USD/Pcs)
Figure 16. Global Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Parkinson's Disease (PD) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Parkinson's Disease (PD) Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Parkinson's Disease (PD) Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Parkinson's Disease (PD) Drugs Average Price by Type (2019-2030) & (USD/Pcs)
Figure 31. Global Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Parkinson's Disease (PD) Drugs Average Price by Application (2019-2030) & (USD/Pcs)
Figure 34. North America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Parkinson's Disease (PD) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Parkinson's Disease (PD) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 54. China Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Parkinson's Disease (PD) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Parkinson's Disease (PD) Drugs Market Drivers
Figure 75. Parkinson's Disease (PD) Drugs Market Restraints
Figure 76. Parkinson's Disease (PD) Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Parkinson's Disease (PD) Drugs in 2023
Figure 79. Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
Figure 80. Parkinson's Disease (PD) Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Parkinson's Disease (PD) Drugs Picture
Figure 2. Global Parkinson's Disease (PD) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Type in 2023
Figure 4. Dopamine Agonist Examples
Figure 5. Monoamine Oxidase Inhibitors Examples
Figure 6. Acetylcholinesterase Inhibitors Examples
Figure 7. Glutamate Inhibitors Examples
Figure 8. Global Parkinson's Disease (PD) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. Family Examples
Figure 12. Global Parkinson's Disease (PD) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Parkinson's Disease (PD) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Parkinson's Disease (PD) Drugs Sales Quantity (2019-2030) & (K Pcs)
Figure 15. Global Parkinson's Disease (PD) Drugs Average Price (2019-2030) & (USD/Pcs)
Figure 16. Global Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Parkinson's Disease (PD) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Parkinson's Disease (PD) Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Parkinson's Disease (PD) Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Parkinson's Disease (PD) Drugs Average Price by Type (2019-2030) & (USD/Pcs)
Figure 31. Global Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Parkinson's Disease (PD) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Parkinson's Disease (PD) Drugs Average Price by Application (2019-2030) & (USD/Pcs)
Figure 34. North America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Parkinson's Disease (PD) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Parkinson's Disease (PD) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Parkinson's Disease (PD) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 54. China Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Parkinson's Disease (PD) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Parkinson's Disease (PD) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Parkinson's Disease (PD) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Parkinson's Disease (PD) Drugs Market Drivers
Figure 75. Parkinson's Disease (PD) Drugs Market Restraints
Figure 76. Parkinson's Disease (PD) Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Parkinson's Disease (PD) Drugs in 2023
Figure 79. Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
Figure 80. Parkinson's Disease (PD) Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
More Publications
Global Chronic Kidney Disease (CKD) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
US$ 3,480.00
October 2018
137 pages
Global Dry Eye Disease Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
July 2024
137 pages
Global POC Infectious Diseases Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
US$ 3,480.00
January 2019
124 pages
Global Parkinsons Disease Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
July 2024
119 pages
North America and Europe Alzheimer’s Disease Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023
US$ 4,480.00
March 2018
103 pages
